annual cash & cash equivalents:
$194.61M-$82.17M(-29.69%)Summary
- As of today (July 27, 2025), CRL annual cash & cash equivalents is $194.61 million, with the most recent change of -$82.17 million (-29.69%) on December 28, 2024.
- During the last 3 years, CRL annual cash & cash equivalents has fallen by -$46.61 million (-19.32%).
- CRL annual cash & cash equivalents is now -29.69% below its all-time high of $276.77 million, reached on December 30, 2023.
Performance
CRL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$229.36M+$34.75M(+17.86%)Summary
- As of today (July 27, 2025), CRL quarterly cash & cash equivalents is $229.36 million, with the most recent change of +$34.75 million (+17.86%) on March 29, 2025.
- Over the past year, CRL quarterly cash & cash equivalents has dropped by -$97.68 million (-29.87%).
- CRL quarterly cash & cash equivalents is now -50.72% below its all-time high of $465.41 million, reached on March 27, 2021.
Performance
CRL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | -29.9% |
| 3 y3 years | -19.3% | -5.2% |
| 5 y5 years | -18.2% | -38.4% |
CRL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.7% | at low | -29.9% | +45.9% |
| 5 y | 5-year | -29.7% | at low | -50.7% | +45.9% |
| alltime | all time | -29.7% | +1196.5% | -50.7% | +1142.6% |
CRL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $229.36M(+17.9%) |
| Dec 2024 | $194.61M(-29.7%) | $194.61M(-7.4%) |
| Sep 2024 | - | $210.17M(+17.3%) |
| Jun 2024 | - | $179.21M(-45.2%) |
| Mar 2024 | - | $327.04M(+18.2%) |
| Dec 2023 | $276.77M(+18.3%) | $276.77M(+76.1%) |
| Sep 2023 | - | $157.17M(-21.6%) |
| Jun 2023 | - | $200.44M(-0.6%) |
| Mar 2023 | - | $201.59M(-13.8%) |
| Dec 2022 | $233.91M(-3.0%) | $233.91M(+20.8%) |
| Sep 2022 | - | $193.70M(-3.3%) |
| Jun 2022 | - | $200.32M(-17.2%) |
| Mar 2022 | - | $241.87M(+0.3%) |
| Dec 2021 | $241.21M(+5.6%) | $241.21M(+13.5%) |
| Sep 2021 | - | $212.54M(-4.7%) |
| Jun 2021 | - | $222.97M(-52.1%) |
| Mar 2021 | - | $465.41M(+103.7%) |
| Dec 2020 | $228.42M(-4.0%) | $228.42M(-6.0%) |
| Sep 2020 | - | $242.88M(-39.6%) |
| Jun 2020 | - | $402.02M(+7.9%) |
| Mar 2020 | - | $372.43M(+56.5%) |
| Dec 2019 | $238.01M(+21.8%) | $238.01M(+44.5%) |
| Sep 2019 | - | $164.76M(-17.9%) |
| Jun 2019 | - | $200.59M(+58.8%) |
| Mar 2019 | - | $126.32M(-35.4%) |
| Dec 2018 | $195.44M(+19.3%) | $195.44M(+40.7%) |
| Sep 2018 | - | $138.87M(-27.8%) |
| Jun 2018 | - | $192.30M(+2.4%) |
| Mar 2018 | - | $187.77M(+14.6%) |
| Dec 2017 | $163.79M(+39.2%) | $163.79M(+32.5%) |
| Sep 2017 | - | $123.62M(+6.1%) |
| Jun 2017 | - | $116.47M(-11.4%) |
| Mar 2017 | - | $131.52M(+11.8%) |
| Dec 2016 | $117.63M(-0.3%) | $117.63M(+11.3%) |
| Sep 2016 | - | $105.72M(-31.6%) |
| Jun 2016 | - | $154.59M(-1.8%) |
| Mar 2016 | - | $157.38M(+33.4%) |
| Dec 2015 | $117.95M(-26.3%) | $117.95M(+59.3%) |
| Sep 2015 | - | $74.03M(-50.9%) |
| Jun 2015 | - | $150.81M(-0.7%) |
| Mar 2015 | - | $151.92M(-5.1%) |
| Dec 2014 | $160.02M(+2.6%) | $160.02M(+22.4%) |
| Sep 2014 | - | $130.75M(+11.7%) |
| Jun 2014 | - | $117.01M(-31.1%) |
| Mar 2014 | - | $169.85M(+8.9%) |
| Dec 2013 | $155.93M(+42.2%) | $155.93M(+19.5%) |
| Sep 2013 | - | $130.45M(+14.9%) |
| Jun 2013 | - | $113.52M(+13.0%) |
| Mar 2013 | - | $100.42M(-8.4%) |
| Dec 2012 | $109.69M | $109.69M(+31.8%) |
| Sep 2012 | - | $83.22M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $76.08M(+24.7%) |
| Mar 2012 | - | $61.03M(-11.4%) |
| Dec 2011 | $68.91M(-61.5%) | $68.91M(-15.2%) |
| Sep 2011 | - | $81.22M(-44.3%) |
| Jun 2011 | - | $145.83M(-8.1%) |
| Mar 2011 | - | $158.75M(-11.4%) |
| Dec 2010 | $179.16M(-1.9%) | $179.16M(+30.4%) |
| Sep 2010 | - | $137.43M(-37.3%) |
| Jun 2010 | - | $219.08M(-1.4%) |
| Mar 2010 | - | $222.20M(+21.7%) |
| Dec 2009 | $182.57M(-25.0%) | $182.57M(-5.0%) |
| Sep 2009 | - | $192.20M(+24.2%) |
| Jun 2009 | - | $154.81M(-9.1%) |
| Mar 2009 | - | $170.23M(-30.1%) |
| Dec 2008 | $243.59M(+8.0%) | $243.59M(+14.4%) |
| Sep 2008 | - | $212.85M(-18.9%) |
| Jun 2008 | - | $262.44M(+9.4%) |
| Mar 2008 | - | $239.88M(+6.4%) |
| Dec 2007 | $225.45M(+28.5%) | $225.45M(+22.9%) |
| Sep 2007 | - | $183.50M(+13.2%) |
| Jun 2007 | - | $162.05M(+18.7%) |
| Mar 2007 | - | $136.54M(-22.1%) |
| Dec 2006 | $175.38M(+52.7%) | $175.38M(-30.8%) |
| Sep 2006 | - | $253.50M(+31.3%) |
| Jun 2006 | - | $193.07M(+90.3%) |
| Mar 2006 | - | $101.46M(-11.6%) |
| Dec 2005 | $114.82M(-44.7%) | $114.82M(-31.5%) |
| Sep 2005 | - | $167.71M(+0.7%) |
| Jun 2005 | - | $166.55M(-21.8%) |
| Mar 2005 | - | $213.06M(+2.6%) |
| Dec 2004 | $207.57M(+13.8%) | $207.57M(-20.0%) |
| Sep 2004 | - | $259.41M(+15.7%) |
| Jun 2004 | - | $224.15M(+18.1%) |
| Mar 2004 | - | $189.75M(+4.1%) |
| Dec 2003 | $182.33M(+48.8%) | $182.33M(+11.0%) |
| Sep 2003 | - | $164.32M(+13.8%) |
| Jun 2003 | - | $144.34M(+26.6%) |
| Mar 2003 | - | $114.01M(-6.9%) |
| Dec 2002 | $122.51M(+110.2%) | $122.51M(+9.0%) |
| Sep 2002 | - | $112.39M(+32.7%) |
| Jun 2002 | - | $84.71M(-37.4%) |
| Mar 2002 | - | $135.40M(+132.4%) |
| Dec 2001 | $58.27M(+75.9%) | $58.27M(-25.6%) |
| Sep 2001 | - | $78.30M(+175.6%) |
| Jun 2001 | - | $28.42M(-60.8%) |
| Mar 2001 | - | $72.40M(+118.5%) |
| Dec 2000 | $33.13M(+120.7%) | $33.13M(+18.3%) |
| Sep 2000 | - | $28.01M(+47.5%) |
| Jun 2000 | - | $18.99M(+2.9%) |
| Mar 2000 | - | $18.46M |
| Dec 1999 | $15.01M(-39.5%) | - |
| Dec 1998 | $24.81M | - |
FAQ
- What is Charles River Laboratories International, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual cash & cash equivalents year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents year-on-year change?
What is Charles River Laboratories International, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CRL is $194.61M
What is the all time high annual cash & cash equivalents for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual cash & cash equivalents is $276.77M
What is Charles River Laboratories International, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CRL annual cash & cash equivalents has changed by -$82.17M (-29.69%)
What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CRL is $229.36M
What is the all time high quarterly cash & cash equivalents for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly cash & cash equivalents is $465.41M
What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CRL quarterly cash & cash equivalents has changed by -$97.68M (-29.87%)